1. A Fig. 1, Lambotin et al. CD11cIL-3RBDCA2 pDCs CD80CD86 mDCs B pDCs mDCs SR-BICLDN1CD81DC-SIGN C p=0.023 n.s.

2. Fig. 2, Lambotin et al. number of E2 positive cells/ total number of cells (n=300) 100 120 0 20 40 60 80 pDCsmDCs p = 0.012 DE % inhibition of HCVcc utpake pDCsmDCs % inhibition of HCVcc utpake Anti-HCV Anti-SR-BI Anti-CLDN1 Anti-CD81 0 20 40 60 80 100 0 20 40 60 80 100 Anti-HCV Anti-SR-BI Anti-CLDN1 Anti-CD81 A mDCspDCs Copies HCV RNA/ µg cellular RNA rat IgG PBS NC mouse IgG Anti-CD81 Anti-SR-BI Anti-CLDN1 Anti-DC-SIGN rat IgG PBS NC mouse IgG Anti-CD81 Anti-SR-BI Anti-CLDN1 Anti-DC-SIGN 10 7 10 6 10 5 10 4 10 3 10 2 10 1 10 0 10 7 10 6 10 5 10 4 10 3 10 2 10 1 10 0 Copies HCV RNA/ µg cellular RNA pDCs mDCs + HCVcc B NC C mDCs Anti-E2Anti-core overlay pDCs

3. Fig. 3, Lambotin et al. pDCsmDCs A HCV E2Rab5Overlay HCV E2Lamp1Overlay HCV E2CD71Overlay HCV E2Rab5Overlay HCV E2Lamp1Overlay HCV E2CD71Overlay B CD71MHC IOverlay CD71MHC IIOverlay Lamp1MHC IOverlay Lamp1MHC IIOverlay